<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/"
xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
xmlns:EMSArticle="http://webdoc.advanstar.com/rss/module/EMSArticle"
xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://pharmtech.findpharma.com/pharmtech/servlet/pharmtech_40943.rss?id=40943">
    <title>Pharmaceutical Technology - Analytics</title>

    <link>http://pharmtech.findpharma.com/pharmtech/Analytics/Article/list/40943</link>

    <description>Analytical testing methods in pharma manufacturing. Chromatography, UHPLC, chiral. Near-infrared (NIR)
    and Raman spectroscopy. Anticounterfeiting. Dissolution testing. Cleaning validation. Extracables &amp;
    leachables.</description>

    <items>
      <rdf:Seq>
        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Choosing-the-best-construction-material-for-powder/ArticleStandard/Article/detail/641749?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Challenges-and-Strategies-for-Implementing-Automat/ArticleStandard/Article/detail/638760?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Getting-the-Truth-out-of-Dissolution-Testing/ArticleStandard/Article/detail/631721?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Statistical+Solutions/Square-Root-of-emNem---1-Sampling-Plan/ArticleStandard/Article/detail/631722?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Inside-USP-Characterization-of-Heparin-Products/ArticleStandard/Article/detail/632995?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Pharma-Capsules/ArticleStandard/Article/detail/631712?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/Verification-Methods-for-198-Common-Raw-Materials-/ArticleStandard/Article/detail/631708?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Quality+by+Design/Academia-Tackles-QbD-Science-NIPTE-Carries-out-FDA/ArticleStandard/Article/detail/632993?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/The-Relevance-of-Continuous-Solid-Oral-Dosage-Proc/ArticleStandard/Article/detail/631713?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Bayer-Receives-Warning-Letter-for-Alleged-Deviatio/ArticleStandard/Article/detail/628581?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Implementing-QbD-Powder-characterization-for-desig/ArticleStandard/Article/detail/625969?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Inside-IPECndashAmericas-Evaluating-Excipient-Stab/ArticleStandard/Article/detail/624205?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/625569?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-benefits-of-risk-based-analyses-during-system-/ArticleStandard/Article/detail/621294?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Tale-of-Two-Thermals/ArticleStandard/Article/detail/622361?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/NIR-Prediction-of-Solid-Dosage-Form-Dissolution-Pr/ArticleStandard/Article/detail/621674?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-Osmolality-and-pH-in-Bioreac/ArticleStandard/Article/detail/621669?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/Extending-Calibrations-for-Near-Infrared-Assay-of-/ArticleStandard/Article/detail/621672?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-and-FDA-To-Collaborate-on-Good-Clinical-Pract/ArticleStandard/Article/detail/616595?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/A-Dubious-Foundation-for-Quality-Control/ArticleStandard/Article/detail/615814?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/615826?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Comparison-of-Authentic-and-Suspect-Pharmaceutical/ArticleStandard/Article/detail/615820?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/615818?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Outsourcing-Stability-Studies/ArticleStandard/Article/detail/615513?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Personalized-Medicine-May-Lead-to-More-Mergers/ArticleStandard/Article/detail/614823?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/News/Final-Guidance-on-Listing-Drug-Substance-Impuritie/ArticleStandard/Article/detail/612969?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Article/The-Debate-over-Preuse-Filter-Integrity-Testing/ArticleStandard/Article/detail/612612?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Better-Wet-Granulation-Development-Scale-Up-and-Ma/ArticleStandard/Article/detail/610802?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Pharma-Capsules/ArticleStandard/Article/detail/607457?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Cleaning-Verification-Method-Development-and-Valid/ArticleStandard/Article/detail/608708?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Less-Is-More-for-Low-Dose-Drugs/ArticleStandard/Article/detail/607458?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Aqueous-Cleaning-for-Pharmaceutical-Applications/ArticleStandard/Article/detail/476613?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Charting-a-Pathway-to-Follow-On-Biologics/ArticleStandard/Article/detail/600817?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Static-Electricity-The-Hidden-Danger/ArticleStandard/Article/detail/600996?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Requests-Largest-Ever-Budget-Increase/ArticleStandard/Article/detail/597992?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Easing-the-Bottleneck/ArticleStandard/Article/detail/596044?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/596429?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Ingredients/Industry-Leaders-Debate-Follow-on-Biologics-Pathwa/ArticleStandard/Article/detail/596043?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Identification-of-Fungi-Using-Ribosomal-Internal-T/ArticleStandard/Article/detail/595863?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Answers-Key-Residual-Solvent-Testing-Questions/ArticleStandard/Article/detail/595618?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Analytics/FDA-Issues-Guidance-on-Summaries-for-CTD-based-Sub/ArticleStandard/Article/detail/594586?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Forms-Collaboration-with-Russia/ArticleStandard/Article/detail/593447?contextCategoryId=40943&amp;ref=25" />

        <rdf:li
        resource="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-to-Divide-Research-Activities-into-Two-Bran/ArticleStandard/Article/detail/592339?contextCategoryId=40943&amp;ref=25" />
      </rdf:Seq>
    </items>

    <dc:date>2009-11-21T20:24:28Z</dc:date>
  </channel>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40943&amp;ref=25">

    <title>Week of Nov. 16, 2009: GSK and Nabi Form Nicotine Vaccine Agreement; Eli Lilly Research Exec to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-16-2009-GSK-and-Nabi-Form-Nicotine-Vac/ArticleStandard/Article/detail/642581?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: Genzyme provides updates on enzyme replacement products and FDA complete
    response letter; Watson appoints VP of global operations; more...</description>

    <dc:date>2009-11-19T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/472009/642581null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Choosing-the-best-construction-material-for-powder/ArticleStandard/Article/detail/641749?contextCategoryId=40943&amp;ref=25">

    <title>Choosing the best construction material for powder processing equipment</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Choosing-the-best-construction-material-for-powder/ArticleStandard/Article/detail/641749?contextCategoryId=40943&amp;ref=25</link>

    <description>Selecting the best material of construction is a crucial part of the plant design process, the aim
    being to balance performance and cost to best advantage. For powder processors, choosing a material that eases flow
    can pay dividends throughout the lifetime of the plant, but there is limited data on which to base this decision. A
    recent study by Freeman Technology highlights the role of the FT4 universal powder tester for such studies and
    provides some valuable comparative data for a wide range of commercially available materials and
    finishes.</description>

    <dc:date>2009-11-13T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/641749null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40943&amp;ref=25">

    <title>AAPS Announces Annual Awards, Names 2009 Fellows</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/AAPS-Announces-Annual-Awards-Names-2009-Fellows/ArticleStandard/Article/detail/640909?contextCategoryId=40943&amp;ref=25</link>

    <description>The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the
    organization's 2009 Annual Meeting and Exposition in Los Angeles this week.</description>

    <dc:date>2009-11-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640909null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40943&amp;ref=25">

    <title>Week of Nov. 9, 2009: Merck and Schering-Plough Begin Combined Operations; UCB Appoints VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Nov-9-2009-Merck-and-Schering-Plough-Begin/ArticleStandard/Article/detail/640959?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: 3M forms agreement with VaxInnate; TRIN Pharma appoints CEO;
    More...</description>

    <dc:date>2009-11-12T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/462009/640959null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?contextCategoryId=40943&amp;ref=25">

    <title>SOCMA Hails FDA Action on Citizen Petition Regarding Inspections</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/SOCMA-Hails-FDA-Action-on-Citizen-Petition-Regardi/ArticleStandard/Article/detail/639211?contextCategoryId=40943&amp;ref=25</link>

    <description>The Society of Chemical Manufacturers and Affiliates (SOCMA) reported last week that the US Food and
    Drug Administration responded to the association's citizen petition relating to the inspection process of foreign
    drug-manufacturing facilities.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639211null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?contextCategoryId=40943&amp;ref=25">

    <title>ICH Adopts Pharmacopeial Text Annexes and Prepares for Global Quality Implementation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/ICH-Adopts-Pharmacopeial-Text-Annexes-and-Prepares/ArticleStandard/Article/detail/638997?contextCategoryId=40943&amp;ref=25</link>

    <description>Last week, the steering committee and expert working groups of the International Conference on
    Harmonization (ICH) met in St. Louis, Missouri. A major success of the meeting was the adoption of several annexes
    to ICH Q4B on pharmacopeial texts.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638997null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40943&amp;ref=25">

    <title>Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson &amp;amp;amp; Johnson Announces Restructuring;
    PPD Acquires Chinese CRO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Nov-2-2009-Eli-Lilly-Opens-Biotech-Center-/ArticleStandard/Article/detail/639212?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its
    business team.</description>

    <dc:date>2009-11-05T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639212null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40943&amp;ref=25">

    <title>Stay Afloat with Lessons Learned</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Stay-Afloat-with-Lessons-Learned/ArticleStandard/Article/detail/639195?contextCategoryId=40943&amp;ref=25</link>

    <description>FDA's Edwin Rivera-Martinez on dodging supply-chain challenges.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639195null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40943&amp;ref=25">

    <title>DIY Healthcare Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/DIY-Healthcare-Reform/ArticleStandard/Article/detail/639194?contextCategoryId=40943&amp;ref=25</link>

    <description>While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the
    game too.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639194null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?contextCategoryId=40943&amp;ref=25">

    <title>A Robust, Automated Karl Fischer Titration System</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/A-Robust-Automated-Karl-Fischer-Titration-System/ArticleStandard/Article/detail/639198?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors developed a robust, automated system to conduct Karl Fischer moisture assays for
    lyophilized products.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639198/pt-1109-fig-2-p58B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639198null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40943&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/639200?contextCategoryId=40943&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639200null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?contextCategoryId=40943&amp;ref=25">

    <title>Regulatory Update: The IPEC Novel Excipient Safety Evaluation Procedure</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Regulatory-Update-The-IPEC-Novel-Excipient-Safety-/ArticleStandard/Article/detail/639204?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors, representing the International Pharmaceutical Excipients Council, propose a new
    evaluation procedure, including tiered toxicology testing for excipients.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639204null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?contextCategoryId=40943&amp;ref=25">

    <title>Sharing Supply-Chain Security</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Sharing-Supply-Chain-Security/ArticleStandard/Article/detail/639209?contextCategoryId=40943&amp;ref=25</link>

    <description>A panel of industry and regulatory experts, including FDA, discuss efforts to secure the global
    pharmaceutical supply chain. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-11-02T05:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/pt1109_coverstory_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/639209null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Challenges-and-Strategies-for-Implementing-Automat/ArticleStandard/Article/detail/638760?contextCategoryId=40943&amp;ref=25">

    <title>Challenges and Strategies for Implementing Automated Visual Inspection for Biopharmaceuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Challenges-and-Strategies-for-Implementing-Automat/ArticleStandard/Article/detail/638760?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors used a light-transmission-based static division system to detect particles of foreign
    contaminants in prefilled vials.</description>

    <dc:date>2009-11-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638760/pt-1109supp-p25-fig1B_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/452009/638760null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40943&amp;ref=25">

    <title>Week of Oct. 26, 2009: OXiGENE to Acquire VaxGen; Warner Chilcott Appoints Global R&amp;amp;amp;D President;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-26-2009-OXiGENE-to-Acquire-VaxGen-Warn/ArticleStandard/Article/detail/637174?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Astellas and Medivation sign development pact; WuXi PharmaTech appoints VP of business
    development, more...</description>

    <dc:date>2009-10-29T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/442009/637174null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40943&amp;ref=25">

    <title>Week of Oct. 19, 2009: Lonza Drops Bid for Patheon; Peregrine Appoints Head of Regulatory Affairs;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-19-2009-Lonza-Drops-Bid-for-Patheon-Pe/ArticleStandard/Article/detail/635533?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: SurModics forms agreement with Roche and Genentech; Hospira names Daphne
    Jones senior VP and chief information officer; more...</description>

    <dc:date>2009-10-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/432009/635533null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40943&amp;ref=25">

    <title>Week of Oct. 12, 2009: GSK and Prosensa Form Pact; Cardiokine Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-12-2009-GSK-and-Prosensa-Form-Pact-Car/ArticleStandard/Article/detail/633981?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: Bayer Schering Pharma forms collaboration with Compugen; Takeda San
    Francisco appoints VP of process science; more...</description>

    <dc:date>2009-10-15T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/422009/633981null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40943&amp;ref=25">

    <title>Week of Oct. 5, 2009: Merck and CSL Sign Flu Vaccine Pact; Cardinal Health Names VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Oct-5-2009-Merck-and-CSL-Sign-Flu-Vaccine-/ArticleStandard/Article/detail/632124?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: GSK forms joint venture with China-based Jiangsu Walvax Biotech;
    Sigma-Aldrich appoints VP and board member; more...</description>

    <dc:date>2009-10-08T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632124null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Getting-the-Truth-out-of-Dissolution-Testing/ArticleStandard/Article/detail/631721?contextCategoryId=40943&amp;ref=25">

    <title>Getting the Truth out of Dissolution Testing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Getting-the-Truth-out-of-Dissolution-Testing/ArticleStandard/Article/detail/631721?contextCategoryId=40943&amp;ref=25</link>

    <description>Industry, equipment vendors, and regulators are busy refining the precision and reliability of
    dissolution testing.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631721/Coverstory_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631721null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Statistical+Solutions/Square-Root-of-emNem---1-Sampling-Plan/ArticleStandard/Article/detail/631722?contextCategoryId=40943&amp;ref=25">

    <title>Square Root of (N) + 1 Sampling Plan</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Statistical+Solutions/Square-Root-of-emNem---1-Sampling-Plan/ArticleStandard/Article/detail/631722?contextCategoryId=40943&amp;ref=25</link>

    <description>Is the square root of (N) + 1 a statistically valid scheme?</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631722null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Inside-USP-Characterization-of-Heparin-Products/ArticleStandard/Article/detail/632995?contextCategoryId=40943&amp;ref=25">

    <title>Inside USP: Characterization of Heparin Products</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Inside+Standards/Inside-USP-Characterization-of-Heparin-Products/ArticleStandard/Article/detail/632995?contextCategoryId=40943&amp;ref=25</link>

    <description>USP workshop participants support new methods to safeguard heparin products but desire international
    harmonization. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632995/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632995null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40943&amp;ref=25">

    <title>PhRMA's Stake in Reform</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/PhRMAs-Stake-in-Reform/ArticleStandard/Article/detail/631752?contextCategoryId=40943&amp;ref=25</link>

    <description>The nation's healtcare system needs an overhaul, but it has to be done right.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631752null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Pharma-Capsules/ArticleStandard/Article/detail/631712?contextCategoryId=40943&amp;ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Pharma-Capsules/ArticleStandard/Article/detail/631712?contextCategoryId=40943&amp;ref=25</link>

    <description>Brief pharmaceutical news items for October 2009.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631712null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/Verification-Methods-for-198-Common-Raw-Materials-/ArticleStandard/Article/detail/631708?contextCategoryId=40943&amp;ref=25">

    <title>Verification Methods for 198 Common Raw Materials Using a Handheld Raman Spectrometer</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/Verification-Methods-for-198-Common-Raw-Materials-/ArticleStandard/Article/detail/631708?contextCategoryId=40943&amp;ref=25</link>

    <description>Using handheld Raman spectroscopy, methods were developed and evaluated for 198 substances widely used
    as raw materials.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631708/72_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631708null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Quality+by+Design/Academia-Tackles-QbD-Science-NIPTE-Carries-out-FDA/ArticleStandard/Article/detail/632993?contextCategoryId=40943&amp;ref=25">

    <title>Academia Tackles QbD Science: NIPTE Carries out FDA Grant and Educational Initiatives</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Special+Section%3A+Quality+by+Design/Academia-Tackles-QbD-Science-NIPTE-Carries-out-FDA/ArticleStandard/Article/detail/632993?contextCategoryId=40943&amp;ref=25</link>

    <description>A review of NIPTE's core projects and its plans for training-and retraining-the pharmaceutical
    industry.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632993/QBD_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632993/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/632993null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/The-Relevance-of-Continuous-Solid-Oral-Dosage-Proc/ArticleStandard/Article/detail/631713?contextCategoryId=40943&amp;ref=25">

    <title>The Relevance of Continuous Solid Oral Dosage Processing and NIR Spectroscopy In Meeting the Needs of QbD
    and PAT</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/The-Relevance-of-Continuous-Solid-Oral-Dosage-Proc/ArticleStandard/Article/detail/631713?contextCategoryId=40943&amp;ref=25</link>

    <description>The author discusses control strategies via near infrared instrumentation for continuous mixing,
    granulation, drying, and extrusion with a more focused detail on mixing.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631713/112_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631713null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40943&amp;ref=25">

    <title>Looking Ahead: The Pharmaceutical-Science Industry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Looking-Ahead-The-Pharmaceutical-Science-Industry/ArticleStandard/Article/detail/631750?contextCategoryId=40943&amp;ref=25</link>

    <description>AAPS President offers hope and solutions for the industry's challenging future.</description>

    <dc:date>2009-10-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/412009/631750null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40943&amp;ref=25">

    <title>Week of Sept. 28, 2009: J&amp;amp;amp;J and Crucell Enter Collaboration; Pfizer Elects Two Directors;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-28-2009-JampJ-and-Crucell-Enter-Colla/ArticleStandard/Article/detail/630279?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: Boehringer Ingelheim will acquire Wyeth's animal health business; Amsterdam
    Molecular Therapeutics appoints CEO; more...</description>

    <dc:date>2009-10-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/402009/630279null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Bayer-Receives-Warning-Letter-for-Alleged-Deviatio/ArticleStandard/Article/detail/628581?contextCategoryId=40943&amp;ref=25">

    <title>Bayer Receives Warning Letter for Alleged Deviations</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Bayer-Receives-Warning-Letter-for-Alleged-Deviatio/ArticleStandard/Article/detail/628581?contextCategoryId=40943&amp;ref=25</link>

    <description>The US Food and Drug Administration sent Bayer Schering Pharma (Berlin) a Warning Letter on Aug. 5,
    2009, citing deviations from current good manufacturing practice in the manufacture of nonsterile active
    pharmaceutical ingredients (APIs).</description>

    <dc:date>2009-09-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628581null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40943&amp;ref=25">

    <title>Week of Sept. 21, 2009: AstraZeneca and Nektar Sign License Agreement; Eli Lilly Names President of Lilly
    USA, More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-21-2009-AstraZeneca-and-Nektar-Sign-L/ArticleStandard/Article/detail/628576?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: Wyeth and Ambrx form development pact; Elite Pharma appoints CEO and CSO;
    more...</description>

    <dc:date>2009-09-24T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/392009/628576null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40943&amp;ref=25">

    <title>Week of Sept. 14, 2009: Evotec and Biogen Idec Form Pact; Marijn Dekkers Leaves Thermo Fisher Scientific for
    Bayer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-14-2009-Evotec-and-Biogen-Idec-Form-P/ArticleStandard/Article/detail/626906?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: Sanofi Pasteur signs H1N1 vaccine deal with Brazilian government; Helsinn
    Group appoints CEO of US business; more...</description>

    <dc:date>2009-09-17T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/382009/626906null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Implementing-QbD-Powder-characterization-for-desig/ArticleStandard/Article/detail/625969?contextCategoryId=40943&amp;ref=25">

    <title>Implementing QbD: Powder characterization for design space definition</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Implementing-QbD-Powder-characterization-for-desig/ArticleStandard/Article/detail/625969?contextCategoryId=40943&amp;ref=25</link>

    <description>For those seeking to adopt a Quality by Design approach to pharmaceutical development and manufacture,
    effective definition of the 'design space' is a key activity. This paper considers the role of modern powder
    testers such as the FT4 from Freeman Technology, within this context.</description>

    <dc:date>2009-09-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/625969null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40943&amp;ref=25">

    <title>Week of Sept. 7, 2009: Facet Rejects Biogen Idec's Proposal; Roche Announces Management Changes;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Sept-7-2009-Facet-Rejects-Biogen-Idecs-Pro/ArticleStandard/Article/detail/624922?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: Neoprobe and Laureate Pharma form manufacturing agreement; Akela Pharma
    appoints CEO and chairman; more...</description>

    <dc:date>2009-09-10T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624922null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40943&amp;ref=25">

    <title>Week of Aug. 31, 2009: Roche Purchases Lonza Facility; SCOLR Pharma Names CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Week-of-Aug-31-2009-Roche-Purchases-Lonza-Facility/ArticleStandard/Article/detail/623587?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Orexo and Novartis form agreement; Affitech appoints Robert Burns CEO; more...</description>

    <dc:date>2009-09-03T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/623587null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Inside-IPECndashAmericas-Evaluating-Excipient-Stab/ArticleStandard/Article/detail/624205?contextCategoryId=40943&amp;ref=25">

    <title>Inside IPEC&amp;amp;ndash;Americas: Evaluating Excipient Stability</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Inside-IPECndashAmericas-Evaluating-Excipient-Stab/ArticleStandard/Article/detail/624205?contextCategoryId=40943&amp;ref=25</link>

    <description>IPEC's new stability testing guide takes into account the full supply chain's storage
    conditions.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624205null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/625569?contextCategoryId=40943&amp;ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/625569?contextCategoryId=40943&amp;ref=25</link>

    <description>Brief pharmaceutical news items for September 2009.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/625569null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40943&amp;ref=25">

    <title>The Go/No-Go Mindset</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/The-GoNo-Go-Mindset/ArticleStandard/Article/detail/624651?contextCategoryId=40943&amp;ref=25</link>

    <description>As new process validation guidelines emerge, industry needs to reinvent how it releases
    product.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/372009/624651null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40943&amp;ref=25">

    <title>Quality by Enforcement</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Quality-by-Enforcement/ArticleStandard/Article/detail/624202?contextCategoryId=40943&amp;ref=25</link>

    <description>After years of promomting QbD concepts, FDA's ready to take action on nonconformers.</description>

    <dc:date>2009-09-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/362009/624202null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-benefits-of-risk-based-analyses-during-system-/ArticleStandard/Article/detail/621294?contextCategoryId=40943&amp;ref=25">

    <title>The benefits of risk-based analyses during system validation</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Peer-Reviewed+Research/The-benefits-of-risk-based-analyses-during-system-/ArticleStandard/Article/detail/621294?contextCategoryId=40943&amp;ref=25</link>

    <description>When validating automated systems from third-party providers, using the V model and failure modes
    effects and criticality analysis (FMECA) early in the process can help.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:thumbnailImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621294/Woods_thumbnail.jpg</EMSArticle:thumbnailImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621294null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Tale-of-Two-Thermals/ArticleStandard/Article/detail/622361?contextCategoryId=40943&amp;ref=25">

    <title>A Tale of Two Thermals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/A-Tale-of-Two-Thermals/ArticleStandard/Article/detail/622361?contextCategoryId=40943&amp;ref=25</link>

    <description>Part one of the three?part core technology white paper series discusses the principle of operations of
    capillary thermal and immersible thermal gas mass flow measurement technologies. Taken together, these two methods
    cover a wide spectrum of gas mass flow measurements typically found in industrial applications.</description>

    <dc:date>2009-09-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/622361null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40943&amp;ref=25">

    <title>Week of Aug. 24, 2009: Warner Chilcott Buys P&amp;amp;amp;G Pharma Business; Amylin Appoints Former Novartis
    Exec As Chairman; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Week-of-Aug-24-2009-Warner-Chilcott-Buys-PampG-Pha/ArticleStandard/Article/detail/621551?contextCategoryId=40943&amp;ref=25</link>

    <description>Company and People Notes: UCB and Novartis form agreement; AAIPharma appoints VP of regulatory
    affairs; more...</description>

    <dc:date>2009-08-27T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621551null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/NIR-Prediction-of-Solid-Dosage-Form-Dissolution-Pr/ArticleStandard/Article/detail/621674?contextCategoryId=40943&amp;ref=25">

    <title>NIR Prediction of Solid Dosage Form Dissolution Profiles</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/NIR-Prediction-of-Solid-Dosage-Form-Dissolution-Pr/ArticleStandard/Article/detail/621674?contextCategoryId=40943&amp;ref=25</link>

    <description>It can be concluded from this study that Near-Infrared (NIR) prediction of dissolution profiles of
    intact tablets provides a fast and accurate means of non-destructively assessing tablets that is in step with the
    FDA Process Analytical Technology (PAT) initiatives. The data showed promising results that could relieve
    laboratory workload from dissolution testing. NIR was able to predict dissolution profiles for tablets with
    different levels of acetyltributyl citrate (ATBC) closely replicating the error of the lab method.</description>

    <dc:date>2009-08-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621674null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-Osmolality-and-pH-in-Bioreac/ArticleStandard/Article/detail/621669?contextCategoryId=40943&amp;ref=25">

    <title>In Situ Monitoring of Osmolality and pH in Bioreactors Using Near-Infrared Spectroscopy</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/In-Situ-Monitoring-of-Osmolality-and-pH-in-Bioreac/ArticleStandard/Article/detail/621669?contextCategoryId=40943&amp;ref=25</link>

    <description>Near-Infrared Spectroscopy (NIRS) can monitor a bioreactor in situ and in real time, so it is capable
    of replacing or supplementing osmolality and pH measurements off-line or current on-line pH methods. NIRS may be
    used to improve cell viability and productivity with closed-loop feedback.</description>

    <dc:date>2009-08-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621669null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/Extending-Calibrations-for-Near-Infrared-Assay-of-/ArticleStandard/Article/detail/621672?contextCategoryId=40943&amp;ref=25">

    <title>Extending Calibrations for Near-Infrared Assay of Tablets Using Synthetic Modeling and Variance from
    Placebos</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/Extending-Calibrations-for-Near-Infrared-Assay-of-/ArticleStandard/Article/detail/621672?contextCategoryId=40943&amp;ref=25</link>

    <description>The range of a Near-Infrared (NIR) calibration model for tablet assay was extended using production
    &amp;#34;seed&amp;#34; spectra and synthetic spectra generated from placebos and &amp;#34;pure&amp;#34; API
    spectra. This method resolves the problem of not being able to obtain a range of production samples with +/- 15% of
    the label claim of API concentration online.</description>

    <dc:date>2009-08-26T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/352009/621672null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Forest Labs and AstraZeneca Form Pact; Endo COO Resigns; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Forest-Labs-and-AstraZene/ArticleStandard/Article/detail/620144?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, XCELERON and GSK form agreement; Millipore appoints VP of life sciences; more...</description>

    <dc:date>2009-08-20T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/342009/620144null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Nabi and GSK Form Pact; Cardinal Health Names CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Nabi-and-GSK-Form-Pact-Ca/ArticleStandard/Article/detail/618405?contextCategoryId=40943&amp;ref=25</link>

    <description>Also: DSM's North Carolina facility receives SafeBridge certification; Dynavax CFO to retire;
    more...</description>

    <dc:date>2009-08-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/332009/618405null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?contextCategoryId=40943&amp;ref=25">

    <title>Near-Infrared Assay and Content Uniformity of Tablets</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Near-Infrared-Assay-and-Content-Uniformity-of-Tabl/ArticleStandard/Article/detail/523511?contextCategoryId=40943&amp;ref=25</link>

    <description>Near-Infrared (NIR) technique for the determination of content uniformity of tablets provides a fast
    and accurate means of monitoring tablet production that is in step with the FDA Process Analytical Technology (PAT)
    initiatives. The FOSS XDS MasterLab&amp;amp;trade; was used to determine the content uniformity of tablets,
    instrument precision and accuracy. The data showed promising results that could relieve laboratory workload from
    HPLC analysis and bring analysis closer to &amp;#34;real-time&amp;#34; for process monitoring.</description>

    <dc:date>2009-08-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242008/523511null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Cherokee and DuPont Form Supply Agreement; Mylan Makes Changes in Management Team;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Cherokee-and-DuPont-Form-/ArticleStandard/Article/detail/616603?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Pfizer forms two research agreements in China; NanoInk appoints John Kubricky to its scientific
    advisory board; more...</description>

    <dc:date>2009-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616603null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-and-FDA-To-Collaborate-on-Good-Clinical-Pract/ArticleStandard/Article/detail/616595?contextCategoryId=40943&amp;ref=25">

    <title>EMEA and FDA To Collaborate on Good Clinical Practice</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/EMEA-and-FDA-To-Collaborate-on-Good-Clinical-Pract/ArticleStandard/Article/detail/616595?contextCategoryId=40943&amp;ref=25</link>

    <description>The US Food and Drug Administration and European Medicines Agency (EMEA) launched this week a joint
    initiative to collaborate on international good clinical practice (GCP) inspection activities.</description>

    <dc:date>2009-08-06T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/322009/616595null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40943&amp;ref=25">

    <title>For Biotherapeutics, Innovation is Not Enough</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/For-Biotherapeutics-Innovation-is-Not-Enough/ArticleStandard/Article/detail/615816?contextCategoryId=40943&amp;ref=25</link>

    <description>Biotech firms must first close the gaps between science and biology on the path toward
    QbD.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615816null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/A-Dubious-Foundation-for-Quality-Control/ArticleStandard/Article/detail/615814?contextCategoryId=40943&amp;ref=25">

    <title>A Dubious Foundation for Quality Control</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics+Article/A-Dubious-Foundation-for-Quality-Control/ArticleStandard/Article/detail/615814?contextCategoryId=40943&amp;ref=25</link>

    <description>The author of an ambitious book about quality control falls short of reaching his goals.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615814/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615814null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/615826?contextCategoryId=40943&amp;ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Pharma-Capsules/ArticleStandard/Article/detail/615826?contextCategoryId=40943&amp;ref=25</link>

    <description>Brief pharmaceutical news items for August 2009.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615826null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Comparison-of-Authentic-and-Suspect-Pharmaceutical/ArticleStandard/Article/detail/615820?contextCategoryId=40943&amp;ref=25">

    <title>Comparison of Authentic and Suspect Pharmaceuticals</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Comparison-of-Authentic-and-Suspect-Pharmaceutical/ArticleStandard/Article/detail/615820?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors applied near-infrared (NIR) spectrophotometry to assess whether eight drug products were
    authentic or counterfeit.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615820null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/615818?contextCategoryId=40943&amp;ref=25">

    <title>In the Spotlight</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/In-the-Spotlight/ArticleStandard/Article/detail/615818?contextCategoryId=40943&amp;ref=25</link>

    <description>Editors' Picks of Pharmaceutical Science &amp;amp;amp; Technology Innovations</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615818null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40943&amp;ref=25">

    <title>Of Hubris and Happy Endings</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Of-Hubris-and-Happy-Endings/ArticleStandard/Article/detail/615813?contextCategoryId=40943&amp;ref=25</link>

    <description>Individuals and companies at the top seem to have no problem short-circuiting their
    success.</description>

    <dc:date>2009-08-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615813null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Outsourcing-Stability-Studies/ArticleStandard/Article/detail/615513?contextCategoryId=40943&amp;ref=25">

    <title>Outsourcing Stability Studies</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Outsourcing+Article/Outsourcing-Stability-Studies/ArticleStandard/Article/detail/615513?contextCategoryId=40943&amp;ref=25</link>

    <description>The author provides advice about evaluating contract analytical laboratories and establishing an
    effective procedure for working with them to perform reliable stability studies.</description>

    <dc:date>2009-08-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/615513null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Personalized-Medicine-May-Lead-to-More-Mergers/ArticleStandard/Article/detail/614823?contextCategoryId=40943&amp;ref=25">

    <title>Personalized Medicine May Lead to More Mergers</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Personalized-Medicine-May-Lead-to-More-Mergers/ArticleStandard/Article/detail/614823?contextCategoryId=40943&amp;ref=25</link>

    <description>The number of alliances between diagnostics companies and pharmaceutical companies is set to rise
    because of the growth of personalized medicine, according to a report from PricewaterhouseCoopers.</description>

    <dc:date>2009-07-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614823null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40943&amp;ref=25">

    <title>Company, People, and Regulatory Notes: Amgen and GSK Collaborate; WuXi Appoints VP of Pharmacology;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Notes-Amgen-and-GSK-/ArticleStandard/Article/detail/614815?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Isogen completes sterile facility; Dishman appoints head of generic API business; FDA releases
    final rule on authorized generic drugs and NDA submissions; more...</description>

    <dc:date>2009-07-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/312009/614815null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/News/Final-Guidance-on-Listing-Drug-Substance-Impuritie/ArticleStandard/Article/detail/612969?contextCategoryId=40943&amp;ref=25">

    <title>Final Guidance on Listing Drug-Substance Impurities in ANDAs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/News/Final-Guidance-on-Listing-Drug-Substance-Impuritie/ArticleStandard/Article/detail/612969?contextCategoryId=40943&amp;ref=25</link>

    <description>The US Food and Drug Administration last week posted the final version of its Guidance for Industry,
    ANDAs: Impurities in Drug Substances.</description>

    <dc:date>2009-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612969null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40943&amp;ref=25">

    <title>Company, People, and Regulatory Briefs: Teva and Ortho Extend Agreement; Biogen Idec Cofounder Retires;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-People-and-Regulatory-Briefs-Teva-and-Orth/ArticleStandard/Article/detail/612961?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Gilead and Tibotec form agreement; FDA approves 2009-2010 flu vaccine; Catalent appoints VP in
    packaging unit; more...</description>

    <dc:date>2009-07-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612961null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Article/The-Debate-over-Preuse-Filter-Integrity-Testing/ArticleStandard/Article/detail/612612?contextCategoryId=40943&amp;ref=25">

    <title>The Debate over Preuse Filter-Integrity Testing</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Article/The-Debate-over-Preuse-Filter-Integrity-Testing/ArticleStandard/Article/detail/612612?contextCategoryId=40943&amp;ref=25</link>

    <description>Drugmakers have the common goal of manufacturing safe and sterile pharmaceutical products and
    understand that the filtration process is a critical means of achieving this goal. Preuse filter-integrity testing
    provides evidence that a filter will perform correctly, has the right pore size, and has been installed
    correctly.</description>

    <dc:date>2009-07-22T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/302009/612612null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Merck and Portola Sign Agreement; Eisai Appoints Senior Vice-Presidents; More
    ...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Merck-and-Portola-Sign-Ag/ArticleStandard/Article/detail/611109?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Lonza and Medarex sign agreement; Covance appoints VP and chief scientific officer of global
    analytical services; more...</description>

    <dc:date>2009-07-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/611109null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Better-Wet-Granulation-Development-Scale-Up-and-Ma/ArticleStandard/Article/detail/610802?contextCategoryId=40943&amp;ref=25">

    <title>Better Wet Granulation: Development, Scale-Up, and Manufacture</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Better-Wet-Granulation-Development-Scale-Up-and-Ma/ArticleStandard/Article/detail/610802?contextCategoryId=40943&amp;ref=25</link>

    <description>Wet granulation is a common unit operation in the pharmaceutical industry, yet accurate endpoint
    detection remains a challenge. The author examines the contribution that dynamic powder rheometry can make,
    highlighting its ability to detect the transition from wet mass to granulate with the required sensitivity.
    Quantification of this transition point, with a measure that is independent of process scale, accelerates
    development and scale-up and improves manufacture.</description>

    <dc:date>2009-07-13T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/292009/610802null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Pfizer and Graceway Form Deal; GeoVax Labs Leader Resigns; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-and-Graceway-Form-/ArticleStandard/Article/detail/609491?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Lundbeck acquired LifeHealth; FDA is seeking a director of its new tobacco regulation branch;
    Charles River Labs announces personnel changes; more...</description>

    <dc:date>2009-07-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/282009/609491null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Pharma-Capsules/ArticleStandard/Article/detail/607457?contextCategoryId=40943&amp;ref=25">

    <title>Pharma Capsules</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Packaging+%26+Labeling+Article/Pharma-Capsules/ArticleStandard/Article/detail/607457?contextCategoryId=40943&amp;ref=25</link>

    <description>Brief pharmaceutical news items for July 2009.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607457null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: GSK and Chroma Form Development Pact; Siemen's Healthcare Appoints US CEO;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-and-Chroma-Form-Devel/ArticleStandard/Article/detail/607999?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Wyeth and Catalyst sign agreement; FDA seeks public opinion about tobacco regulation; Catalent
    appoints VP of quality and regulatory affairs; more...</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607999null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40943&amp;ref=25">

    <title>The Good Society</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/The-Good-Society/ArticleStandard/Article/detail/607467?contextCategoryId=40943&amp;ref=25</link>

    <description>Is it good policy to pay for bad behavior?</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607467null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?contextCategoryId=40943&amp;ref=25">

    <title>USP Collaborates with Asian Authorities</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/USP-Collaborates-with-Asian-Authorities/ArticleStandard/Article/detail/608009?contextCategoryId=40943&amp;ref=25</link>

    <description>This week, the US Pharmacopeial Convention and the Vietnamese Pharmacopoeia Commission signed a
    memorandum of understanding that will help ensure the safety of Vietnamese medicines.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608009null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Cleaning-Verification-Method-Development-and-Valid/ArticleStandard/Article/detail/608708?contextCategoryId=40943&amp;ref=25">

    <title>Cleaning Verification: Method Development and Validation Using Ion Mobility Spectrometry</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Cleaning-Verification-Method-Development-and-Valid/ArticleStandard/Article/detail/608708?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors discuss the theory of ion mobility spectrometry, its benefit over HPLC analysis in
    cleaning verification, and the experimental considerations for method validation and validation.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/608708/Galella1_rotate_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Less-Is-More-for-Low-Dose-Drugs/ArticleStandard/Article/detail/607458?contextCategoryId=40943&amp;ref=25">

    <title>Less Is More for Low-Dose Drugs</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation+Article/Less-Is-More-for-Low-Dose-Drugs/ArticleStandard/Article/detail/607458?contextCategoryId=40943&amp;ref=25</link>

    <description>Developers of low-dose drugs in solid oral dosage forms will find theoretical considerations and
    practical advice in a new book.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607458/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607458null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40943&amp;ref=25">

    <title>Can Industry Learn to Share?</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Can-Industry-Learn-to-Share/ArticleStandard/Article/detail/607463?contextCategoryId=40943&amp;ref=25</link>

    <description>The regulators are doing it. But industry's fear of sharing information may leave them
    behind.</description>

    <dc:date>2009-07-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/272009/607463null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Aqueous-Cleaning-for-Pharmaceutical-Applications/ArticleStandard/Article/detail/476613?contextCategoryId=40943&amp;ref=25">

    <title>Aqueous Cleaning for Pharmaceutical Applications</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Aqueous-Cleaning-for-Pharmaceutical-Applications/ArticleStandard/Article/detail/476613?contextCategoryId=40943&amp;ref=25</link>

    <description>To streamline regulatory compliance, the desirability of using as few cleaners as possible to remove
    the entire range of residues encountered in pharmaceutical manufacturing &amp;amp;mdash; from water-soluble
    excipients to difficult-to-clean petrolatum/metal oxide mixtures &amp;amp;mdash; is explored in the standard
    industry text, The Aqueous Cleaning Handbook. Cleaning validation guidelines and key factors in establishing sound
    GMP and cGMP procedures are discussed. Explaining how aqueous cleaners work in a wide range of cleaning procedures,
    the text covers manual, soak and ultrasonic cleaning as well as clean-in-place (CIP) spray systems. Tables for
    chemical formulations, types of cleaning methods, and aqueous cleaning agents are included. A useful, in-depth
    reference whether you are cleaning bench scale lab apparatus used for trials to full-scale bulk manufacturing
    equipment.</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/482007/476613null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Synta and GSK End Agreement; WuXi Appoints US VP; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Synta-and-GSK-End-Agreeme/ArticleStandard/Article/detail/606500?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Adimab forms deals with Merck and Roche; Manhattan Pharmaceuticals' CEO and president steps
    down; more...</description>

    <dc:date>2009-06-25T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/262009/606500null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Dr. Reddy and GSK Form Pact; Hollis-Eden Appoints CEO; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Dr-Reddy-and-GSK-Form-Pac/ArticleStandard/Article/detail/604472?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, FDA debars clinical investigators; Jubilant Organosys forms deal with Endo Pharmaceuticals; AMRI
    makes changes to its India management team; more...</description>

    <dc:date>2009-06-18T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/252009/604472null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: CSL and Talecris Terminate Merger Agreement; Eli Lilly Hires Former Indianapolis
    Mayor; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CSL-and-Talecris-Terminat/ArticleStandard/Article/detail/602720?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, TorreyPines Therapeutics to liquidate assets and dissolve company; EU's competition services to
    examine Pfizer/Wyeth merger; Akorn appoints Raj Rai interim CEO; more...</description>

    <dc:date>2009-06-11T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/242009/602720null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: AstraZeneca and Merck Collaborate on Cancer Drug; Catalent Appoints Senior VP;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-AstraZeneca-and-Merck-Col/ArticleStandard/Article/detail/601645?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, WACKER expands Iowa facility; EMEA releases a Q&amp;amp;amp;A document for PIPs; Metrics
    consolidates quality operations; more...</description>

    <dc:date>2009-06-04T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601645null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40943&amp;ref=25">

    <title>Beneath the Surface</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Beneath-the-Surface/ArticleStandard/Article/detail/600812?contextCategoryId=40943&amp;ref=25</link>

    <description>It can take a lot of work to make sure nothing happens.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600812null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?contextCategoryId=40943&amp;ref=25">

    <title>Initial Solvent Screening of Carbamazepine, Cimetidine, and Phenylbutazone: Part 2 of 2</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/601168?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors describe the importance of a rapid and an abbreviated screening strategy in initial
    solvent screening. This article contains bonus online-exclusive material.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168/Bonus_main.gif</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601168null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?contextCategoryId=40943&amp;ref=25">

    <title>Quality in, Quality Out</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Quality-in-Quality-Out/ArticleStandard/Article/detail/601167?contextCategoryId=40943&amp;ref=25</link>

    <description>A book guides readers through the regulatory requirements for computerized quality
    systems.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:heroImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601167/onlineEX_main.jpg</EMSArticle:heroImageUrl>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/601167null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40943&amp;ref=25">

    <title>Truth and Transparency</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Truth-and-Transparency/ArticleStandard/Article/detail/600808?contextCategoryId=40943&amp;ref=25</link>

    <description>Misleading the public about their investments&amp;amp;mdash;be it money or medicine&amp;amp;mdash;is
    unacceptable.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600808null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Charting-a-Pathway-to-Follow-On-Biologics/ArticleStandard/Article/detail/600817?contextCategoryId=40943&amp;ref=25">

    <title>Charting a Pathway to Follow-On Biologics</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Charting-a-Pathway-to-Follow-On-Biologics/ArticleStandard/Article/detail/600817?contextCategoryId=40943&amp;ref=25</link>

    <description>Debates about science, manufacturing, and European regulations will shape the approval process for
    follow-on biologics in the United States.</description>

    <dc:date>2009-06-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600817/rotate_cover_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Whitepapers/Static-Electricity-The-Hidden-Danger/ArticleStandard/Article/detail/600996?contextCategoryId=40943&amp;ref=25">

    <title>Static Electricity, The Hidden Danger</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Whitepapers/Static-Electricity-The-Hidden-Danger/ArticleStandard/Article/detail/600996?contextCategoryId=40943&amp;ref=25</link>

    <description>Static Electricity is an ever-present hazard for operations and processes taking place in flammable or
    combustible locations. Sparking caused by electrostatic can provide an ignition source for gases, vapors and dust
    atmospheres. This article explains the background to the hazards of static electricity and provides some guidance
    as to how they may be safely avoided.</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/232009/600996null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>REMOTE</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Pfizer Forms Licensing Agreements; Malvinder Mohan Singh Steps Down at Ranbaxy,
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Pfizer-Forms-Licensing-Ag/ArticleStandard/Article/detail/600299?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Johnson &amp;amp;amp; Johnson acquires Cougar Biotechnology; NIH launches program for rare and
    neglected diseases; PPD restructures leadership positions; more...</description>

    <dc:date>2009-05-28T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/222009/600299null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Teva and Lonza Joint Venture Approved; Novartis CFO to Retire; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Teva-and-Lonza-Joint-Vent/ArticleStandard/Article/detail/599148?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Oxford BioTherapeutics forms drug development pact with GSK; Avila Therapeutics names CEO;
    more...</description>

    <dc:date>2009-05-21T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/212009/599148null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: GSK Forms Pact with Aspen Pharmacare; Sigma-Aldrich Chairman to Retire;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-GSK-Forms-Pact-with-Aspen/ArticleStandard/Article/detail/598063?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Takeda to consolidate operations in Ireland; FDA to redesign website; Archemix names president
    and CEO; more...</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/598063null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Requests-Largest-Ever-Budget-Increase/ArticleStandard/Article/detail/597992?contextCategoryId=40943&amp;ref=25">

    <title>FDA Requests Largest-Ever Budget Increase</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/FDA-Requests-Largest-Ever-Budget-Increase/ArticleStandard/Article/detail/597992?contextCategoryId=40943&amp;ref=25</link>

    <description>On May 7, 2009, as part of the President's fiscal year (FY) 2010 budget, the US Food and Drug
    Administration requested a budget of $3.2 billion, which is 19% more than the agency's current
    budget.</description>

    <dc:date>2009-05-14T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/202009/597992null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: Jubilant Biosys Forms Pact with AstraZeneca; Pfizer Appoints Chief Medical
    Officer; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-Jubilant-Biosys-Forms-Pac/ArticleStandard/Article/detail/597076?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Oxford BioMedica forms collaboration with sanofi-aventis; FDA requires labeling changes for
    botulinum toxin producs; C. Richter King joins IAVI; more...</description>

    <dc:date>2009-05-07T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/597076null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40943&amp;ref=25">

    <title>Shop Floor and Top Floor, Unite!</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Shop-Floor-and-Top-Floor-Unite/ArticleStandard/Article/detail/596049?contextCategoryId=40943&amp;ref=25</link>

    <description>Technology can solve enterprise-level problems.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596049null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Easing-the-Bottleneck/ArticleStandard/Article/detail/596044?contextCategoryId=40943&amp;ref=25">

    <title>Easing the Bottleneck</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Easing-the-Bottleneck/ArticleStandard/Article/detail/596044?contextCategoryId=40943&amp;ref=25</link>

    <description>Manufacturers of therapeutic monoclonal antibodies consider new paradigms in purification
    technologies.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596044/RotateCover_flash.jpg</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/596429?contextCategoryId=40943&amp;ref=25">

    <title>Initial Solvent Screening of Carbamazepine, Cimetidine, and Phenylbutazone: Part 1 of 2</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Initial-Solvent-Screening-of-Carbamazepine-Cimetid/ArticleStandard/Article/detail/596429?contextCategoryId=40943&amp;ref=25</link>

    <description>The authors describe the importance of a rapid and an abbreviated screening strategy by initial
    solvent screening in 20-mL scintillation vials.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/192009/596429null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Ingredients/Industry-Leaders-Debate-Follow-on-Biologics-Pathwa/ArticleStandard/Article/detail/596043?contextCategoryId=40943&amp;ref=25">

    <title>Industry Leaders Debate Follow-on Biologics Pathway</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Ingredients/Industry-Leaders-Debate-Follow-on-Biologics-Pathwa/ArticleStandard/Article/detail/596043?contextCategoryId=40943&amp;ref=25</link>

    <description>The organizations' presidents discuss market exclusivity, approval processes, and pending
    legislation.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596043null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40943&amp;ref=25">

    <title>Biotechnology in 2009</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/IT/Biotechnology-in-2009/ArticleStandard/Article/detail/596053?contextCategoryId=40943&amp;ref=25</link>

    <description>The president of BIO proposes the ingredients needed for industry growth.</description>

    <dc:date>2009-05-02T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/596053null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Identification-of-Fungi-Using-Ribosomal-Internal-T/ArticleStandard/Article/detail/595863?contextCategoryId=40943&amp;ref=25">

    <title>Identification of Fungi Using Ribosomal Internal Transcribed Space DNA Sequences</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics+Article/Identification-of-Fungi-Using-Ribosomal-Internal-T/ArticleStandard/Article/detail/595863?contextCategoryId=40943&amp;ref=25</link>

    <description>Identification of fungi, especially filamentous fungi, has been a very difficult task. Because of the
    amount of experience required to accurately identify filamentous fungi to the species level, it has become
    acceptable to either identify these organisms to the genus level or, in some cases, simply identify them as
    &amp;#34;molds.&amp;#34;</description>

    <dc:date>2009-05-01T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/595863null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>XML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: CIGNA and Merck Agree on Drug Pricing Plan; Kathleen Sebelius Confirmed as head of
    HHS; More</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-CIGNA-and-Merck-Agree-on-/ArticleStandard/Article/detail/595723?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Roche's Avastin trial does not meet endpoint; Innate Pharma names regulatory VP;
    more...</description>

    <dc:date>2009-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/595723null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Answers-Key-Residual-Solvent-Testing-Questions/ArticleStandard/Article/detail/595618?contextCategoryId=40943&amp;ref=25">

    <title>FDA Answers Key Residual-Solvent Testing Questions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Regulation/FDA-Answers-Key-Residual-Solvent-Testing-Questions/ArticleStandard/Article/detail/595618?contextCategoryId=40943&amp;ref=25</link>

    <description>The US Food and Drug Administration has agreed to address some core industry questions regarding the
    changes made to US Pharmacopeia General Chapter &amp;amp;lt;467&amp;amp;gt; in July 2008.</description>

    <dc:date>2009-04-30T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/182009/595618null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Analytics/FDA-Issues-Guidance-on-Summaries-for-CTD-based-Sub/ArticleStandard/Article/detail/594586?contextCategoryId=40943&amp;ref=25">

    <title>FDA Issues Guidance on Summaries for CTD-based Submissions</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Analytics/FDA-Issues-Guidance-on-Summaries-for-CTD-based-Sub/ArticleStandard/Article/detail/594586?contextCategoryId=40943&amp;ref=25</link>

    <description>The US Food and Drug Administration finalized a Guidance for Industry this week that aims to clarify
    the submission of new drug applications (NDAs) and biologics license applicants (BLAs) using the common technical
    document (CTD) format, including the electronic CTD (eCTD).</description>

    <dc:date>2009-04-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/172009/594586null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: GSK Acquires Stiefel Laboratories; Roche Announces Changes at Genentech;
    More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Drug+Delivery/Company-and-People-Notes-GSK-Acquires-Stiefel-Labo/ArticleStandard/Article/detail/594648?contextCategoryId=40943&amp;ref=25</link>

    <description>Also: Sanofi-aventis acquires BiPar Sciences; FDA issues Warning Letter to Chinese heparin
    manufacturer; Halo Pharmaceutical appoints chief scientific officer; more...</description>

    <dc:date>2009-04-23T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/172009/594648null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40943&amp;ref=25">

    <title>Company and People Notes: DSM and Shire Form Pact; Pfizer Names Oncology Unit Exec; More...</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Company+and+People+Notes/Company-and-People-Notes-DSM-and-Shire-Form-Pact-P/ArticleStandard/Article/detail/593691?contextCategoryId=40943&amp;ref=25</link>

    <description>Also, Sanofi-aventis acquires Medley and Laboratorios Kendrick; Eli Lilly's Cook to retire from board;
    more...</description>

    <dc:date>2009-04-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/162009/593691null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Forms-Collaboration-with-Russia/ArticleStandard/Article/detail/593447?contextCategoryId=40943&amp;ref=25">

    <title>USP Forms Collaboration with Russia</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Formulation/USP-Forms-Collaboration-with-Russia/ArticleStandard/Article/detail/593447?contextCategoryId=40943&amp;ref=25</link>

    <description>The United States Pharmacopeial (USP) Convention signed a memorandum of understanding (MOU) with the
    Federal Service on Surveillance in Healthcare and Social Development of the Russian Federation (Roszdravnadzor)
    last week in Moscow.</description>

    <dc:date>2009-04-16T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/162009/593447null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>

  <item
  rdf:about="http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-to-Divide-Research-Activities-into-Two-Bran/ArticleStandard/Article/detail/592339?contextCategoryId=40943&amp;ref=25">

    <title>Pfizer to Divide Research Activities into Two Branches; Provides Pipeline Update</title>

    <link>
    http://pharmtech.findpharma.com/pharmtech/Manufacturing/Pfizer-to-Divide-Research-Activities-into-Two-Bran/ArticleStandard/Article/detail/592339?contextCategoryId=40943&amp;ref=25</link>

    <description>Pfizer outlined the progress of its late-stage pipeline last week and announced this week plans to
    separate its research activities into two organizations, one focused on small molecules and the other on biologics,
    pending the closure of its pending acquisition with Wyeth.</description>

    <dc:date>2009-04-09T04:00:00Z</dc:date>

    <EMSArticle:flashImageUrl>
    http://pharmtech.findpharma.com/pharmtech/data/articlestandard/pharmtech/152009/592339null</EMSArticle:flashImageUrl>

    <EMSArticle:contentFormat>HTML</EMSArticle:contentFormat>
  </item>
</rdf:RDF>


